期刊文献+

影响ⅡB期骨肉瘤术前化疗疗效的多因素分析

Multivariate Analysis of Factors Influencing on Preoperative Chemotherapy Response for Osteosarcoma
下载PDF
导出
摘要 目的探讨和分析相关因素在影响骨肉瘤术前化疗疗效中的意义。方法分析40例骨肉瘤患者的性别、年龄、部位、病程、肿瘤体积、AKP和LDH、化疗前骨肉瘤Pgp表达、化疗方案、化疗后白细胞和淋巴细胞最低值以及X线类型等因素的特点,行多因素Logistic回归分析上述因素对TCNR的影响。结果40例中24例的TCNR>90%(60%);通过单因素分析及多因素非条件Logistic回归分析发现肿瘤体积、化疗后AKP、白细胞最低值及化疗方案与TCNR有相关性(P=0.020,P=0.024,P=0.034,P=0.034),并得出了相关回归方程。结论肿瘤体积、化疗后AKP、化疗后白细胞最低值和化疗方案是影响骨肉瘤术前化疗疗效的最主要因素。肿瘤体积大及化疗后AKP水平高是术前化疗疗效差的危险因素;化疗后白细胞下降的程度可以间接反映术前化疗疗效;DIA方案的疗效优于MMIA方案。 Objective To study the correlation between tumor cell necrosis rate(TCNR) and the possible factors influencing preoperative chemotherapy response for osteosarcoma,with multivariate and univaried analysis,and to investigate the value of those factors in predicting the chemotherapy response.Methods Using clinic opatholigical date of 40 patients with osteosarcoma in our hospital treated with preoperative chemotherapy,the factors such as gender,age,location,duration of symptoms,tumor volume,pre-and post-chemotherapy AKP and LDH,the expression of Pgp before treatment,chemotherapy protocol,the lowest level of blood leucocytes and lymphocyte after chemotherapy,and the type of x-ray appearance,were analyzed and evaluated TCNR after operation.and demanding the influencing pre-and post-chemotherapy changes of the above factors on chemotherapy response with multivariate logistic regression.Results Among 40 patients,24 with TCNR above 90%(60%).We found that,with univaried factor analysis and multivariate non-conditional logistic regression analysis,the relationship existed between TCNR and tumor volume,post-chemotherapy AKP,the lowest level of post-chemotherapy peripheral blood leucocytes and chemotherapy protocol.Conclusion The major factors influencing preoperative chemotherapy response were tumor volume,post-chemotherapy AKP,the lowest level of post-chemotherapy peripheral blood leucocytes and chemotherapy protocol.Larger tumor volume and higher post-chemotherapy AKP were risk factors and predicted poor chemotherapy response.The lowest level of post-chemotherapy blood leucocytes could reflect the chemotherapy response indirectly;the chemotherapy response of DIA protocol was much better than that of MMIA.
作者 于秀淳 王伟
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2009年第10期863-868,共6页 Cancer Research on Prevention and Treatment
关键词 骨肉瘤 术前化疗 化疗疗效 多因素分析 Osteosarcoma Preoperative chemotherapy Chemotherapy response Multivariate analysis
  • 相关文献

参考文献25

  • 1Bacci G, Longhi A, Bertoni F, et al. Primary high-grade osteosarcoma: comparison between preadolescent and older patients [J]. J Pedialr Hematol Oncol, 2005,27(3): 129- 134.
  • 2Shin KH, Moon SH, Suh JS, et al. Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma [J]. Clin Ort hop Relat Res, 2000, (376) : 200-208.
  • 3Bacci G, Ferrari S,Bertoni F, et al. Histologic response of high grade nonmetastatic osteosarcoma of the extremity to chemotherapy [J]. Clin Orthop Relat Res, 2001, (386) : 186- 196.
  • 4Mankin H J, Hornicek FJ, Rosenberg AE, et al. Survival data for 648 patients with osteosarcoma treated at one institution [J]. Clin Orthop Relat Res, 2004, (429):286- 291.
  • 5Wittig JC, Bickels J, Priebal D, et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment [J]. Am Faro Physician,2002,65(6) : 1123- 1132.
  • 6Serra M, Scotlandi K, Reverter-Branchat G, et al. Value of Pglycoprotein and clinicopathologic factors as the basis for new treatment strategies in highgrade osteosarcoma of the extremities [J]. J Clin Oncol, 2003,21 (3) : 536 -542.
  • 7Fuchs N, Bielack SS, Epler D, et al. Long term results of the co operative German-Austrian Swiss osteosarcoma study group 's protocol COS-86 of intensive multidrug chemotherapy and surgery for ostcosarcoma of the limbs [J]. Ann Oncol, 1998,9(8):893-899.
  • 8Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience [J]. J Clin Oncol, 1992,10 ( 1 ) : 5-15.
  • 9Winkler K, Bielack SS, Delling G, et al. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS) [J]. Cancer Treat Res, 1993,62:269 -277.
  • 10于秀淳,刘晓平,周银,李开华.MMIA术前化疗在骨肉瘤保肢术中的意义[J].肿瘤防治研究,2003,30(3):217-220. 被引量:18

二级参考文献18

  • 1[1]Coventry MB and Dahlin DC. Osteogenic sarcoma: A critical analysis of 340 cases. J Bone Joint Surg Am, 1957, 39:741
  • 2[2]Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med, 1986, 314:1600
  • 3[3]Unni KK: Dahlin's Bone Tumors: General Aspects and Data on11, 087 Cases. Ed. 5th. Philadelphia, Lippincott-Raven,1996
  • 4[4]Boyko OB, Cory DA, Cohen MD, et al. MR imaging of osteogenic and Ewing's sarcoma. AJR Am J Roentgenol, 1987, 148:317
  • 5[5]Mankin HJ, Gebhardt MC, Jennings LC, et al. Long-term results of allograft replacement in the management of bone tumors.Clin Orthop, 1996, 324:86
  • 6[6]Muscolo DL, Ayerza MA, and Aponte-Tinao LA. Survivorship and radiographic analysis of knee osteoarticular allografts. Clin Orthop, 2000, 373: 73
  • 7[7]Malawer MM, and Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Joint Surg Am, 1995, 77:1154
  • 8[8]Manfrini M, Gasbarrni A, Malaguti C, et al. Intraepiphyseal resection of the proximal tibia and its impact on lower limb growth. Clin Orthop, 1999, 358: 111
  • 9[9]Eckardt JJ, Kabo JM, Kelley CM, et al. Expandable endoprosthesis reconstruction in skeletally immature patients with tumors. ClinOrthop, 2000, 373:51
  • 10Bramwell V. H. C. The role of chemotherapy in management of nonmetastatic operable extremity osteosarcoma[J]. Semi Oncol, 1997,24(5):561-71.

共引文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部